Articles related to Cardiology, Interventional

A prospective cohort study of 629 patients with non-MRI-conditional ICDs from 2003 to 2013, including 813 MRIs, concludes that the devices continue to function properly after MRI.

When asked whether interventional oncology (IO) has established itself as the fourth pillar of oncology, three eminent interventional oncologists agreed that it is an “ongoing process.” They talked about how to ensure that IOs have a voice in cancer treatment:

This summary of a January 2023 JACC article highlights the study finding that rosuvastatin was “vastly superior to… any of the six supplements studied in the trial.” The study compared rosuvastatin to cinnamon, garlic, turmeric, red yeast rice, fish oil, and plant sterols. Rosuvastatin yielded a reduction in cholesterol of nearly 38 percent in just 28 days. The supplements had little to no effect but were significantly more costly than the statin.

In 60 medical centers, 1,500 patients were randomized to either a restrictive or liberal fluid strategy. The 90-day mortality rate was 14% in the fluid-restrictive group and 14.9% in the liberal group, equating to statistical equivalence between the two approaches.

A layered approach to care is described with lifestyle interventions being a key feature of the updated recommendations. The recommendations now include therapies proven to improve cardiovascular and kidney outcomes in patients with diabetes and CKD.

Commotio cordis — cardiac arrest after a blunt force trauma to the chest — is thought to occur because a hard object strikes the chest in a vulnerable moment in the cardiac cycle, setting off ventricular fibrillation. The rare condition has been described with a ball strike to the chest, but primarily in young men whose chests haven’t fully developed, making them more susceptible to the blunt force of a ball.